TB Vaccines Market Report – Research, Industry Analysis Reports and Market Demands

Global TB Vaccines Market Insights, Forecast to 2025

Request for Sample of this report

Buy now

Table of Content

1 Study Coverage

1.1 TB Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
- 1.4.1 Global TB Vaccines Market Size Growth Rate by Product
- 1.4.2 Mobile
- 1.4.3 Benchtop
1.5 Market by End User
- 1.5.1 Global TB Vaccines Market Size Growth Rate by End User
- 1.5.2 For Water Analysis
- 1.5.3 Measuring
- 1.5.4 Laboratory
- 1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary

2.1 Global TB Vaccines Market Size
- 2.1.1 Global TB Vaccines Revenue 2014-2025
- 2.1.2 Global TB Vaccines Sales 2014-2025
2.2 TB Vaccines Growth Rate by Regions
- 2.2.1 Global TB Vaccines Sales by Regions
- 2.2.2 Global TB Vaccines Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 TB Vaccines Sales by Manufacturers
- 3.1.1 TB Vaccines Sales by Manufacturers
- 3.1.2 TB Vaccines Sales Market Share by Manufacturers
- 3.1.3 Global TB Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 TB Vaccines Revenue by Manufacturers
- 3.2.1 TB Vaccines Revenue by Manufacturers (2014-2019)
- 3.2.2 TB Vaccines Revenue Share by Manufacturers (2014-2019)
3.3 TB Vaccines Price by Manufacturers
3.4 TB Vaccines Manufacturing Base Distribution, Product Types
- 3.4.1 TB Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers TB Vaccines Product Type
- 3.4.3 Date of International Manufacturers Enter into TB Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global TB Vaccines Sales by Product
4.2 Global TB Vaccines Revenue by Product
4.3 TB Vaccines Price by Product

5 Breakdown Data by End User

5.1 Overview
5.2 Global TB Vaccines Breakdown Data by End User

6 North America

6.1 North America TB Vaccines by Countries
- 6.1.1 North America TB Vaccines Sales by Countries
- 6.1.2 North America TB Vaccines Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
6.2 North America TB Vaccines by Product
6.3 North America TB Vaccines by End User

7 Europe

7.1 Europe TB Vaccines by Countries
- 7.1.1 Europe TB Vaccines Sales by Countries
- 7.1.2 Europe TB Vaccines Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
7.2 Europe TB Vaccines by Product
7.3 Europe TB Vaccines by End User

8 Asia Pacific

8.1 Asia Pacific TB Vaccines by Countries
- 8.1.1 Asia Pacific TB Vaccines Sales by Countries
- 8.1.2 Asia Pacific TB Vaccines Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
8.2 Asia Pacific TB Vaccines by Product
8.3 Asia Pacific TB Vaccines by End User

9 Central & South America

9.1 Central & South America TB Vaccines by Countries
- 9.1.1 Central & South America TB Vaccines Sales by Countries
- 9.1.2 Central & South America TB Vaccines Revenue by Countries
- 9.1.3 Brazil
9.2 Central & South America TB Vaccines by Product
9.3 Central & South America TB Vaccines by End User

10 Middle East and Africa

10.1 Middle East and Africa TB Vaccines by Countries
- 10.1.1 Middle East and Africa TB Vaccines Sales by Countries
- 10.1.2 Middle East and Africa TB Vaccines Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
10.2 Middle East and Africa TB Vaccines by Product
10.3 Middle East and Africa TB Vaccines by End User

11 Company Profiles

12 Future Forecast

12.1 TB Vaccines Market Forecast by Regions
- 12.1.1 Global TB Vaccines Sales Forecast by Regions 2019-2025
- 12.1.2 Global TB Vaccines Revenue Forecast by Regions 2019-2025
12.2 TB Vaccines Market Forecast by Product
- 12.2.1 Global TB Vaccines Sales Forecast by Product 2019-2025
- 12.2.2 Global TB Vaccines Revenue Forecast by Product 2019-2025
12.3 TB Vaccines Market Forecast by End User
12.4 North America TB Vaccines Forecast
12.5 Europe TB Vaccines Forecast
12.6 Asia Pacific TB Vaccines Forecast
12.7 Central & South America TB Vaccines Forecast
12.8 Middle East and Africa TB Vaccines Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis
14.2 TB Vaccines Customers
14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
16.2 Author Details

Description

Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch. Today, the only effective tuberculosis vaccine in common use is bacilli Calmette-Guérin (BCG), first used in 1921.About three out of every 10,000 people who get the vaccine experience side effects, which are usually minor except in severely immuno-depressed individuals. While BCG immunization provides fairly effective protection for infants and young children, (including defence against TB meningitis and miliary TB), its efficacy in adults is variable, ranging from 0% to 80%.Several variables have been considered as responsible for the varying outcomes. Demand for TB immunotherapy advancement exists because the disease has become increasingly drug-resistant.
The global TB Vaccines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the TB Vaccines market based on company, product type, end user and key regions.

This report studies the global market size of TB Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of TB Vaccines in these regions.
This research report categorizes the global TB Vaccines market by top players/brands, region, type and end user. This report also studies the global TB Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck & Co.,Inc
Sanofi Pasteur
Japan BCG Laboratory
China National Biotec Group
Serum Institute
India Pvt. Ltd
InterVax Ltd
GreenSignal
Bio Pharma Limited
Statens Serum Institut

Market size by Product
Mobile
Benchtop
Market size by End User
For Water Analysis
Measuring
Laboratory
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global TB Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of TB Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global TB Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of TB Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of TB Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of TB Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.